Rankings
▼
Calendar
TEVA FY 2006 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$34B
FY 2006 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$8.4B
Gross Profit
$4.3B
50.7% margin
Operating Income
$801M
9.5% margin
Net Income
$546M
6.5% margin
EPS (Diluted)
$0.69
Cash Flow
Operating Cash Flow
$2.1B
Free Cash Flow
$1.7B
Stock-Based Comp.
$48M
Balance Sheet
Total Assets
$20.5B
Total Liabilities
$9.3B
Stockholders' Equity
$11.1B
Cash & Equivalents
$1.3B
← FY 2007
All Quarters